Main Street Capital
investment strategy | Main Street Capital
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
9 of 49
Similar slides by Main Street Capital
See diffirences between slides (animation)
Investor Presentation
November 2023
investment strategy | Main Street Capital
Fixed Income
August 2023
investment strategy investment strategy differentiates main from its competitors and provides attractive risk adjusted returns investment objectives high cash yield from secured debt investments weighted average cash coupon as of june plus dividend income fair value appreciation and periodic capital gains from equity investments investments are structured for i protection of capital high recurring income and meaningful capital gain opportunity focus on self sponsored one stop financing opportunities partner with business owners management teams and entrepreneurs provide highly financing solutions recapitalization growth and acquisition capital extensive network of grass roots referral sources strong and growing main street brand recognition reputation investments have low correlation to the debt and equity markets and attractive risk adjusted returns | Main Street Capital
Investor Presentation
August 2023
investment strategy competitors and dividend income fair value appreciation and periodic capital gains | Main Street Capital
Investor Day
June 2023
investment strategy | Main Street Capital
Related slides by other companies
Lazard
Investor Presentation
July 2023
private capital advisory private capital aum spectrum of private market investment strategies growth catalysts total global | Lazard
Saba Capital Management
Activist
March 2024
our nominees plan review all available strategies to close discount capital | Saba Capital Management
M&G
Results
March 2021
delivering long term growth and attractive returns our approach and framework for capital management dividends solvency ratio depending on | M&G
AstraZeneca
Results
November 2023
capital allocation capital allocation strategy unchanged investments to drive future growth reinvestment in the business free post currently projects in phase development investments behind launches in new indications and strengthening leadership in existing therapy areas continued investments in new technologies and platforms including cell and gene therapies progressive dividend policy value accretive deals continue to leverage partnerships to drive innovation and bring medicines to markets priority remains in our business new approvals in major markets | AstraZeneca
Other recent decks by Main Street Capital
See all presentations (7 decks)
Investor Presentation
November 2023
Fixed Income
August 2023
Investor Presentation
August 2023
Investor Day
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io